Search
There is no established standard therapy for the treatment of mantle cell lymphoma (MCL). Instead, there is a range of treatment options and, to date, there has been a dearth of data to assist in clinical decision-making.
Candid conversations cover a wide range of topics for cancer patients and caregivers.
The Hartford HealthCare Cancer Institute has been formally certified as the charter member of the Memorial Sloan Kettering Cancer Alliance, a transformative initiative to improve the quality of care and outcomes for cancer patients in community healthcare settings.
In this Q&A, medical oncologist Emily Feld talks about how metastatic cancer is diagnosed and treated at MSK.
Get to know Abby Hawk, who got a tattoo of Memorial Sloan Kettering after being treated there for neuroblastoma.
A lifelong smoker overcomes discomfort over what a lung cancer imaging test might reveal. She hopes her experience helps reduce the stigma for others who smoke.
New MSK research finds the TCA cycle’s waste-management function may present an opportunity against cancer; shows how microplastics impair immune ‘housekeeping’ functions; reveals the way the protein TOX plays different roles in different immune cells; and identifies a new combination approach for treating advanced kidney cancer after immunotherapy.
Learn how a novel drug is showing promise against lung and pancreatic cancer in early clinical trials by targeting the KRAS G12D mutation with a KRAS degrader.
Anthony DeMaio spent much of his younger life hiding from the spotlight. Today, he lives authentically in his personal and professional life. He also embraces the spotlight more figuratively — through a number of appearances on the small screen.